SpringWorks Therapeutics
Price & Volume
Stats
See more52W Range | $28.21-$62 |
Market Cap | $4.3B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $191.5M |
Revenue Growth (YoY) | 1,030% |
Gross Profit (12 Mos) | $179M |
Diluted EPS | -$3.48 |
News
See moreYahoo Finance • 2 days ago
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Yahoo Finance • 11 days ago
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
About
CEO | Mr. Saqib Islam J.D. |
Address | 100 Washington Boulevard, Stamford, CT, United States, 06902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
